BioXcel cuts over 50% jobs as it pivots focus to retail market for agitation drug
By Sriparna Roy (Reuters) -BioXcel Therapeutics Inc said on Monday it will cut more than half of its workforce, as the drugmaker shifts its focus towards developing its agitation treatment…